WO2023209649 - METHOD OF DNA LINEARIZATION
National phase entry is expected:
Publication Number
WO/2023/209649
Publication Date
02.11.2023
International Application No.
PCT/IB2023/054406
International Filing Date
28.04.2023
Title **
[English]
METHOD OF DNA LINEARIZATION
[French]
PROCÉDÉ DE LINÉARISATION D'ADN
Applicants **
SEQIRUS INC.
Inventors
LONG, Jacquelyn
Priority Data
63/336,342
29.04.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2043 | |
| EPO | Filing, Examination, Granting | 11576 | |
| Japan | Filing, Examination, Granting | 2093 | |
| South Korea | Filing, Examination, Granting | 2004 | |
| USA | Filing, Examination, Granting | 4310 |
Total:
22,026
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
QI restriction endonuclease under conditions to allow the restriction endonuclease to cut the non-linear DNA at its recognition sites.[French]
QI dans des conditions permettant à l'endonucléase de restriction de couper l'ADN non linéaire au niveau de ses sites de reconnaissance.